Warning letter
Quantum Herbal Products: warning letter of Apr 25, 2013
FDA warning letter 332118 · New York District Office
Key facts
| Reference number | 332118 |
|---|---|
| Company | Quantum Herbal Products |
| Subject | CGMP/Manufacturing, Packaging, Labeling, or Holding Operations for Dietary Supplements/Adulterated |
| Issue date | Apr 25, 2013 |
| Posted date | Apr 25, 2013 |
| Issuing office | New York District Office |
| Product type | Food/Cosmetics |
| CFR sections cited | 101.36, 111, 111.75, 111.503, 111.553, 111.560, 111.570, 101.3(g), 101.4(h)(1), 111.70(a), 111.70(e), 111.75(h) and 5 more |
| Inspection city | Saugerties |
| Inspection ZIP | 12477 |
| Inspection start date | Jun 13, 2012 |
| Letter on fda.gov | web.archive.org |
At a glance
- 10–99 CFR sections cited
- OAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: